Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 203.70
+2.99 (1.49%)
Nov 11, 2026, 1:55 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 7.12 billion as of November 10, 2026. Its market cap has decreased by 15.98% in one year.
Market Cap
7.12B
Enterprise Value
9.38B
Revenue
6.76B
Global Rank
n/a
Country Rank
n/a
PE Ratio
14.69
ChartMarket Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 7.12B, an increase of 302.98%. That is a compound annual growth rate of 6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 7.12B | -10.12% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |
| Anlon Healthcare | 14.35B |
| Jagsonpal Pharmaceuticals | 14.06B |
| Bafna Pharmaceuticals | 10.75B |
| Sigachi Industries | 10.53B |